Amedeo Smart

Free Medical Literature Service


 

Amedeo

Malignant Lymphoma

  Free Subscription

18.08.2025

1 Am J Hematol
2 Blood
1 BMC Cancer
3 Br J Haematol
1 J Clin Oncol
3 Leuk Lymphoma
1 PLoS One



    Am J Hematol

  1. GAUTHIER J, Ahn KW, Patel J, Lian Q, et al
    CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis.
    Am J Hematol. 2025 Aug 11. doi: 10.1002/ajh.70033.
    >> Share


    Blood

  2. CASULO C, Sehn LH
    Treatment of Relapsed and Refractory Follicular Lymphoma: Which Treatment for Which Patient for Which Line of Therapy?
    Blood. 2025 Aug 14:blood.2024026018. doi: 10.1182/blood.2024026018.
    >> Share

  3. QIU L, Thakral B
    Intrasinusoidal pleomorphic mantle cell lymphoma mimicking intravascular large B-cell lymphoma.
    Blood. 2025;146:897.
    >> Share


    BMC Cancer

  4. NGUYEN TTH, Do HN, Le TY, Nguyen TT, et al
    Venous thromboembolism risk in newly diagnosed lymphoma patients: a real-world prospective observational study from Vietnam National Cancer Hospital.
    BMC Cancer. 2025;25:1301.
    >> Share


    Br J Haematol

  5. TE VRUGT M, Newman H, Teachey DT, Burkhardt B, et al
    T-cell lymphoblastic lymphoma in children, adolescents and young adults.
    Br J Haematol. 2025 Aug 13. doi: 10.1111/bjh.70053.
    >> Share

  6. MORIMOTO S, Jo T, Kitawaki T, Sakamoto T, et al
    Prolonged chimeric antigen receptor-T apheresis to infusion time is associated with inferior outcomes in diffuse large B-cell lymphoma.
    Br J Haematol. 2025 Aug 11. doi: 10.1111/bjh.70090.
    >> Share

  7. TRAB T, Ranadottir T, Chanchiri I, Ludvigsen Al-Mashhadi A, et al
    Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish nationwide population-based study.
    Br J Haematol. 2025 Aug 8. doi: 10.1111/bjh.70082.
    >> Share


    J Clin Oncol

  8. ROSCHEWSKI M, Kurtz DM, Westin JR, Lynch RC, et al
    Remission Assessment by Circulating Tumor DNA in Large B-cell Lymphoma.
    J Clin Oncol. 2025 Aug 13:101200JCO2501534. doi: 10.1200/JCO-25-01534.
    >> Share


    Leuk Lymphoma

  9. TOLU SS, Gribbin C, Chen Z, Seshadri MR, et al
    Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agents.
    Leuk Lymphoma. 2025 Aug 14:1-11. doi: 10.1080/10428194.2025.2540437.
    >> Share

  10. JEFFREY A, Favaloro J, Wolyncewicz G, Horgan L, et al
    Spontaneous remission of Epstein-Barr virus positive diffuse large B-cell lymphoma after relapse post axicabtagene ciloleucel chimeric antigen receptor T-cell therapy.
    Leuk Lymphoma. 2025 Aug 12:1-5. doi: 10.1080/10428194.2025.2545928.
    >> Share

  11. GORDON ER, Tolu S, Lapolla BA, Trager MH, et al
    Romidepsin and mogamulizumab sequential treatment for advanced cutaneous T-cell lymphoma.
    Leuk Lymphoma. 2025 Aug 11:1-8. doi: 10.1080/10428194.2025.2542941.
    >> Share


    PLoS One

  12. ALANAZI TM
    Enhancing precision in lymphoma detection with novel deep transformer-based neural networks.
    PLoS One. 2025;20:e0329261.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016